Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Zappasodi

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Current Hematologic Malignancy Reports|August 31, 2018
Strategies for Predicting Response to Checkpoint InhibitorsRoberta Zappasodi, Jedd D Wolchok, Taha Merghoub
Methods in Cell Biology|February 13, 2026
Flow-cytometry-based assay to study CD8<sup>+</sup> T cell cytotoxicity against tumor cellsAlexey V Sarapulov, Marc-Anthony Rodriguez, Roberta Zappasodi
Frontiers in Immunology|September 22, 2015
Lymphoma Immunotherapy: Current StatusRoberta Zappasodi, Filippo de Braud, Massimo Di Nicola
Methods in Enzymology|January 18, 2020
In vitro assays for effector T cell functions and activity of immunomodulatory antibodiesRoberta Zappasodi, Sadna Budhu, Mohsen Abu-Akeel, et al.
Journal of Geriatric Oncology|June 15, 2026
Efficacy of immunotherapy in older adults with triple-negative breast cancer: A systematic reviewCarrie Sha, Marie Liu, Ashley Schreier, et al.
Frontiers in Oncology|January 27, 2023
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancerAshley Schreier, Roberta Zappasodi, Inna Serganova, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination TherapiesInna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
The Journal of Experimental Medicine|October 17, 2025
Women in STEM becoming independent: Put science and discovery ahead of your egoPriyadharshini Devarajan, Roberta Zappasodi, Novalia Pishesha, et al.
Haematologica|August 30, 2008
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cellsRoberta Zappasodi, Massimo Di Nicola, Carmelo Carlo-Stella, et al.
Critical Reviews in Oncology/Hematology|July 4, 2016
Immunotherapy advances in uro-genital malignanciesRaffaele Ratta, Roberta Zappasodi, Daniele Raggi, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Current Hematologic Malignancy Reports|August 31, 2018
Strategies for Predicting Response to Checkpoint InhibitorsRoberta Zappasodi, Jedd D Wolchok, Taha Merghoub
Methods in Cell Biology|February 13, 2026
Flow-cytometry-based assay to study CD8<sup>+</sup> T cell cytotoxicity against tumor cellsAlexey V Sarapulov, Marc-Anthony Rodriguez, Roberta Zappasodi
Frontiers in Immunology|September 22, 2015
Lymphoma Immunotherapy: Current StatusRoberta Zappasodi, Filippo de Braud, Massimo Di Nicola
Methods in Enzymology|January 18, 2020
In vitro assays for effector T cell functions and activity of immunomodulatory antibodiesRoberta Zappasodi, Sadna Budhu, Mohsen Abu-Akeel, et al.
Journal of Geriatric Oncology|June 15, 2026
Efficacy of immunotherapy in older adults with triple-negative breast cancer: A systematic reviewCarrie Sha, Marie Liu, Ashley Schreier, et al.
Frontiers in Oncology|January 27, 2023
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancerAshley Schreier, Roberta Zappasodi, Inna Serganova, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination TherapiesInna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
The Journal of Experimental Medicine|October 17, 2025
Women in STEM becoming independent: Put science and discovery ahead of your egoPriyadharshini Devarajan, Roberta Zappasodi, Novalia Pishesha, et al.
Haematologica|August 30, 2008
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cellsRoberta Zappasodi, Massimo Di Nicola, Carmelo Carlo-Stella, et al.
Critical Reviews in Oncology/Hematology|July 4, 2016
Immunotherapy advances in uro-genital malignanciesRaffaele Ratta, Roberta Zappasodi, Daniele Raggi, et al.
Pageof 7